Minomic Launches U.S. Study of MiCheck Prostate Cancer Screening Test

Minomic Launches U.S. Study of MiCheck Prostate Cancer Screening Test
Minomic International, an Australian immuno-oncology company, has initiated a prospective trial of its MiCheck Prostate Cancer Screening Test in the United States to further verify the technology’s accuracy and reliability in detecting prostate cancer. MiCheck works by analyzing a patient’s blood sample to detect the presence of prostate cancer. For this trial, 50 healthy control

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *